mateon.comInvestor Overview | Mateon Therapeutics

mateon.com Profile

mateon.com

Title:Investor Overview | Mateon Therapeutics

Description：The Investor Relations website contains information about Mateon Therapeutics's business for stockholders, potential investors, and financial analysts.

Discover mateon.com website stats, rating, details and status online.Use our online tools to find owner and admin contact info. Find out where is server located.Read and write reviews or vote to improve it ranking. Check alliedvsaxis duplicates with related css, domain relations, most used words, social networks references. Go to regular site

mateon.com Information

Website / Domain:	mateon.com
HomePage size:	72.224 KB
Page Load Time:	0.482795 Seconds
Website IP Address:	184.168.131.241
Isp Server:	GoDaddy.com LLC

mateon.com Ip Information

Ip Country:	United States
City Name:	Scottsdale
Latitude:	33.601974487305
Longitude:	-111.88791656494

mateon.com Keywords accounting

Keyword	Count

mateon.com Httpheader

Accept-Ranges: bytes
Content-Encoding: gzip
Content-Language: en
Content-Type: text/html; charset=UTF-8
device: desktop
ETag: "1608209980"
Expect-CT: max-age=0, report-uri="/report-expect-ct-violation"
Feature-Policy: "accelerometer none;ambient-light-sensor none;autoplay self;camera none;encrypted-media none;fullscreen self;geolocation self;gyroscope none;magnetometer none;microphone none;midi none;payment none;picture-in-picture none;speaker self;sync-xhr self;usb none;vibrate none;vr none", From-Origin: same
Last-Modified: Thu, 17 Dec 2020 12:59:40 GMT
Link: http://investor.mateon.com/; rel="shortlink", http://investor.mateon.com/investor-relations/; rel="canonical", http://investor.mateon.com/investor-relations; rel="alternate"; hreflang="en", http://investor.mateon.com/investor-relations; rel="revision"
Referrer-Policy: no-referrer-when-downgrade
X-Age: 0
X-Content-Type-Options: nosniff
X-Drupal-Dynamic-Cache: UNCACHEABLE
X-Frame-Options: SAMEORIGIN
X-Request-ID: v-b9b46754-4067-11eb-8691-9b0408e03385
X-UA-Compatible: IE=edge
X-XSS-Protection: 1; mode=block
Content-Length: 15181
Cache-Control: public, max-age=0, s-maxage=1800
Expires: Thu, 17 Dec 2020 13:19:23 GMT
Date: Thu, 17 Dec 2020 13:19:23 GMT
Connection: keep-alive
Vary: Accept-Encoding
Set-Cookie: DrupalVisitorMobile=0; path=/; Secure; HttpOnly

mateon.com Meta Info

charset="utf-8"/
content="Mateon Therapeutics" property="og:site_name"/
content="website" property="og:type"/
content="The Investor Relations website contains information about Mateon Therapeutics's business for stockholders, potential investors, and financial analysts." name="description"/
content="http://investor.mateon.com/investor-relations" property="og:url"/
content="Investor Overview \| Mateon Therapeutics" property="og:title"/
content="no-referrer" name="referrer"/
content="The Investor Relations website contains information about Mateon Therapeutics's business for stockholders, potential investors, and financial analysts." property="og:description"/
content="Drupal 8 (https://www.drupal.org)" name="Generator"/
content="width" name="MobileOptimized"/
content="true" name="HandheldFriendly"/
content="width=device-width, initial-scale=1.0" name="viewport"/

184.168.131.241 Domains

Domain	WebSite Title

mateon.com Similar Website

Domain	WebSite Title
tgtherapeutics.com	Investor Relations TG Therapeutics Inc
ir.tgtherapeutics.com	Investor Relations \| TG Therapeutics, Inc.
investors.revance.com	Investor Relations - Revance Therapeutics, Inc.
investor.mateon.com	Investor Overview \| Mateon Therapeutics
insysrx.com	INVESTOR OVERVIEW Insys Therapeutics Inc
mateon.com	Investor Overview \| Mateon Therapeutics
ir.bioxceltherapeutics.com	Investor Relations :: BioXcel Therapeutics, Inc. (BTAI)
nelnetinvestors.com	Nelnet Inc - Investor Resources - Investor Services Program
parkerdrilling.investorroom.com	Exantas Investor Relations - Investor Overview
investor.wgo.net	Winnebago Investor Relations Investor Home
sparktx.com	Spark Therapeutics
ir.nektar.com	About Us \| Nektar Therapeutics
unither.com	United Therapeutics
ir.ptcbio.com	Investors \| PTC Therapeutics, Inc.
jobs.ebbsleep.com	Careers \| Ebb Therapeutics

mateon.com Traffic Sources Chart

mateon.com Alexa Rank History Chart

mateon.com Html To Plain Text

Skip to main navigation Home COVID-19 ARTIVeda Pipeline EdgePoint About Us Investors Investors & News Investor Overview Press Releases Stock Quote SEC Filings Events & Presentations Investor Contacts Alerts Corporate Governance Contact Home COVID-19 ARTIVeda Pipeline EdgePoint About Us Investors Investors & News Investor Overview Press Releases Stock Quote SEC Filings Events & Presentations Investor Contacts Alerts Corporate Governance Contact Enter your keyword Search Efficiently Creating Value with Innovative Science Investors & News Investor Overview Press Releases Stock Quote SEC Filings Events & Presentations Investor Contacts Alerts Corporate Governance Day High: Day Low: Volume: 8:58 PM EST Dec 14, 2020 Data Provided by Refinitiv. Minimum 15 minutes delayed. Intra 3 mo. 6 mo. 1 yr. Investor Overview We are committed to leveraging our intellectual property and the product development expertise of our highly experienced management team to enable vascular targeted therapy to realize its true potential and to bring much needed new therapies for orphan oncology indications to cancer patients worldwide. We have a portfolio of preclinical and clinical stage candidates focused on areas of significant unmet need that we believe can bring significant value to our shareholders. Our common stock is traded on the OTCQB Market under the symbol “MATN”. POSITIVE EARLY RESULTS FOR ARTIVEDA TM IN TREATING COVID-19. Download this Report (PDF 480 KB) Click HERE for Stonegate analyst report. Click HERE for Zacks SCR analyst report. Click HERE for Zacks SCR upgrade analyst report- 12/16/2020. Click HERE for Litchfield Hills Research analyst report. We are headquartered in Agoura Hills, California. Learn More Jun 15, 2020 2019 Annual Report 966.4 KB Press Releases Dec 09, 2020 MATEON TO HOST VIRTUAL WEBINAR ADDRESSING COVID-19 AND THERAPIES AYURVEDA AND ARTEMISIA ON DECEMBER 16, 2020 Nov 30, 2020 DEVELOPMENT UPDATE FOR ARTIVEDA™/ARTISHIELD™ AGAINST COVID-19 View all press releases Events & Presentations Oct 13 - Oct 15, 2020 BIO Investor Forum Digital View all events & presentations Shareholder Tools Email Alerts Email Alerts Downloads Downloads Print Print Share Share Search Search Facebook LinkedIn Twitter RSS About Mateon Mateon Therapeutics is a biopharmaceutical company seeking to realize the full potential of vascular targeted therapy (VTT) in orphan oncology indications. VTTs include vascular disrupting agents (VDAs) such as the investigational drugs that Mateon is developing, and anti-angiogenic agents (AAs), a number of which are FDA approved and widely used in cancer treatment. These 2 approaches (VDAs and AAs) have distinct yet complementary mechanisms of action. At Mateon, we believe that we can significantly improve cancer therapy by combining these 2 complementary approaches. Links Home COVID-19 Pipeline EdgePoint About Us Investors Contact Our Office Mateon Corporate Headquarters 29397 Agoura Road, Suite 107 Agoura Hills, CA 91301 info@mateon.com (650) 635-7000 (650) 635-7001 Copyright © 2020 Mateon Therapeutics, Inc., Terms and Privacy Policy...

mateon.com Whois

"domain_name": [ "MATEON.COM", "mateon.com" ], "registrar": "GoDaddy.com, LLC", "whois_server": "whois.godaddy.com", "referral_url": null, "updated_date": [ "2016-05-20 16:57:25", "2016-03-24 21:57:31" ], "creation_date": "2004-03-23 23:44:48", "expiration_date": "2026-03-23 22:44:48", "name_servers": [ "NS21.DOMAINCONTROL.COM", "NS22.DOMAINCONTROL.COM" ], "status": [ "clientDeleteProhibited https://icann.org/epp#clientDeleteProhibited", "clientRenewProhibited https://icann.org/epp#clientRenewProhibited", "clientTransferProhibited https://icann.org/epp#clientTransferProhibited", "clientUpdateProhibited https://icann.org/epp#clientUpdateProhibited", "clientTransferProhibited http://www.icann.org/epp#clientTransferProhibited", "clientUpdateProhibited http://www.icann.org/epp#clientUpdateProhibited", "clientRenewProhibited http://www.icann.org/epp#clientRenewProhibited", "clientDeleteProhibited http://www.icann.org/epp#clientDeleteProhibited" ], "emails": [ "abuse@godaddy.com", "mateon.com@domainsbyproxy.com" ], "dnssec": "unsigned", "name": "Registration Private", "org": "Domains By Proxy, LLC", "address": [ "DomainsByProxy.com", "14455 N. Hayden Road" ], "city": "Scottsdale", "state": "Arizona", "zipcode": "85260", "country": "US"